Product information and disease descriptionProduct descriptionProduct informationDosing and administration
Administration
3 evidence topics · 2 sources
First-line metastatic uveal melanoma, in combination with crizotinib
Product information and disease descriptionProduct descriptionProduct informationDosing and administration
3 evidence topics · 2 sources